Professor Nike Bello is a Consultant Gynaecologist at the University College Hospital (UCH), Ibadan and the National Coordinating Investigator of the WOMAN-3 Trial, which is being conducted in collaboration with the London School of Hygiene & Tropical Medicine. In this interview with Sade Oguntola, she addresses common causes of anaemia in Nigeria and the WOMAN-3 Trial, an international clinical study investigating whether tranexamic acid (TXA), a drug already used to reduce bleeding, can help prevent anaemia associated with menstrual blood loss.
How common is anaemia among young Nigerian women today? Why most cases only treated when they become severe?
Population surveys suggest that anaemia affects about 29 percent of women of reproductive age in Nigeria, making it a major public health problem. Studies among women in Lagos and Delta States report similar figures, indicating that anaemia remains common across different groups.
Many cases are only detected when they become severe
This post was originally published on this site.
